CPRX P/E ratio: current value, 10-year range and year-by-year history
Cash & Leverage
CPRX's p/e ratio is higher than 65% of the last 10 years.
P/E ratio History
CPRX P/E ratio by year
Yearly range of CPRX’s p/e ratio from 2016 to 2026. Over the full period it ranged from -60.6 to 68.1, averaging 8.4.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 13.3 | 15.9 | 18.2 | 18.2 |
| 2025 | 11.5 | 14.3 | 19.6 | 13.9 |
| 2024 | 15.9 | 26.4 | 39.5 | 15.9 |
| 2023 | 11.6 | 19.5 | 33.3 | 32.3 |
| 2022 | 13.7 | 21.3 | 32.0 | 30.5 |
| 2021 | 4.9 | 9.5 | 19.1 | 18.3 |
| 2020 | 4.4 | 10.0 | 17.7 | 4.7 |
| 2019 | -60.6 | -2.5 | 68.1 | 12.8 |
| 2018 | -18.7 | -13.9 | -5.8 | -5.8 |
| 2017 | -21.4 | -11.3 | -5.0 | -19.0 |
| 2016 | -5.1 | -4.6 | -4.0 | -4.4 |
Get notified when CPRX P/E ratio crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.
Price / Earnings Per ShareThe chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.
- Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
- A falling P/E trend may signal a business in structural decline, not a buying opportunity.
Is CPRX P/E ratio High or Low Right Now?
Catalyst Pharmaceuticals, Inc.'s P/E ratio is currently 18.2, which is above average relative to its 10-year historical range. The 10-year median P/E ratio for CPRX is approximately 12.9. See all CPRX valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.